110 related articles for article (PubMed ID: 20111903)
61. Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.
Lin H; Lin D; Zheng C
Diagn Pathol; 2014 Jan; 9():15. PubMed ID: 24443924
[TBL] [Abstract][Full Text] [Related]
62. The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis.
Zeng W; Xu W; Long W
BMC Cancer; 2024 Jun; 24(1):738. PubMed ID: 38879503
[TBL] [Abstract][Full Text] [Related]
63. Meta-analysis on the association of nucleotide excision repair gene XPD A751C variant and cancer susceptibility among Indian population.
Mandal RK; Yadav SS; Panda AK
Mol Biol Rep; 2014 Feb; 41(2):713-9. PubMed ID: 24362511
[TBL] [Abstract][Full Text] [Related]
64. XPD Asp312Asn polymorphism is a risk factor for prostate cancer.
Liao SG; Liu L; Wang Y; Zhang YY; Wang YJ
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1689-95. PubMed ID: 22644997
[TBL] [Abstract][Full Text] [Related]
65. The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: a systematic review and meta-analysis.
Liu D; Wu D; Li H; Dong M
Gene; 2014 Apr; 538(2):209-16. PubMed ID: 24486506
[TBL] [Abstract][Full Text] [Related]
66. Contribution of xeroderma pigmentosum complementation group D gene polymorphisms in breast and ovarian cancer susceptibility: A protocol for systematic review and meta analysis.
Tian Y; Lin X; Yang F; Zhao J; Yao K; Bian C
Medicine (Baltimore); 2020 May; 99(21):e20299. PubMed ID: 32481313
[TBL] [Abstract][Full Text] [Related]
67. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis.
Feng Z; Ni Y; Dong W; Shen H; Du J
Mol Biol Rep; 2012 Jan; 39(1):57-69. PubMed ID: 21614524
[TBL] [Abstract][Full Text] [Related]
68. [The association of XPD G312A polymorphism with lung cancer risk: a meta-analysis].
Mei C; Deng W; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):526-32. PubMed ID: 20677654
[TBL] [Abstract][Full Text] [Related]
69. [The Association between Polymorphisms of XPD and Susceptibility of Lung Cancer: A meta Analysis.].
Jia Z; Yin Z; Guan P; Zhou B
Zhongguo Fei Ai Za Zhi; 2009 Oct; 12(10):1079-84. PubMed ID: 20723346
[TBL] [Abstract][Full Text] [Related]
70. The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects.
Yao L; Qiu LX; Yu L; Yang Z; Yu XJ; Zhong Y; Hu XC; Yu L
Breast Cancer Res Treat; 2010 Aug; 123(1):227-31. PubMed ID: 20127278
[TBL] [Abstract][Full Text] [Related]
71. Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects.
Hu YY; Yuan H; Jiang GB; Chen N; Wen L; Leng WD; Zeng XT; Niu YM
PLoS One; 2012; 7(4):e35220. PubMed ID: 22536360
[TBL] [Abstract][Full Text] [Related]
72. ERCC2/XPD polymorphisms and lung cancer risk.
Christiani DC
J Thorac Oncol; 2011 Jan; 6(1):233; author reply 233-5. PubMed ID: 21178723
[No Abstract] [Full Text] [Related]
73. Association of EGF rs4444903 and XPD rs13181 polymorphisms with cutaneous melanoma in Caucasians.
Liu J; Song J; Wang MY; He L; Cai L; Chou KC
Med Chem; 2015; 11(6):551-9. PubMed ID: 25537294
[TBL] [Abstract][Full Text] [Related]
74. Genetic polymorphisms may influence the vertical growth rate of melanoma.
Sikora M; Rudnicka L; Borkowska B; Kardynał A; Słowińska M; Rakowska A; Warszawik-Hendzel O; Wiergowska A; Ługowska I; Rutkowski P; Dębniak T; Lubiński J; Olszewska M
J Cancer; 2018; 9(17):3078-3083. PubMed ID: 30210630
[No Abstract] [Full Text] [Related]
75. Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso.
Adico MDW; Zouré AA; Sombié HK; Kiendrebeogo TI; Dabré S; Amegnona LJ; Bakyono BS; Traoré L; Ouedraogo TC; Ouedraogo RA; Zohoncon TM; Yonli AT; Bayala B; Bambara HA; Djigma FW; Simpore J
Mol Genet Genomic Med; 2023 Apr; 11(4):e2134. PubMed ID: 36594475
[TBL] [Abstract][Full Text] [Related]
76. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
77. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
Xiao F; Pu J; Wen Q; Huang Q; Zhang Q; Huang B; Huang S; Lan A; Zhang Y; Li J; Zhao D; Shen J; Wu H; He Y; Li H; Yang X
Oncotarget; 2017 Jul; 8(29):48488-48506. PubMed ID: 28489582
[TBL] [Abstract][Full Text] [Related]
78. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population.
He BS; Xu T; Pan YQ; Wang HJ; Cho WC; Lin K; Sun HL; Gao TY; Wang SK
Oncotarget; 2016 Dec; 7(51):84872-84882. PubMed ID: 27768589
[TBL] [Abstract][Full Text] [Related]
79. XPD Lys
Yang QI; Wei YF; Zhang Y; Huang GM
Exp Ther Med; 2015 Jun; 9(6):2406-2414. PubMed ID: 26136996
[TBL] [Abstract][Full Text] [Related]
80. Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study.
Shadrina AS; Ermolenko NA; Boyarskikh UA; Sinkina TV; Lazarev AF; Petrova VD; Filipenko ML
Clin Exp Med; 2016 Feb; 16(1):21-8. PubMed ID: 25537147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
